kabutan

Kidswell Bio, Operating Loss Forecast for the Fiscal Year Revised Upward to 100-100 Million Yen Loss

Thu Feb 12, 2026 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE Growth] announced its financial results after the market closed on February 12th (16:00). The consolidated operating profit/loss for the cumulative third quarter of the fiscal year ending March 2026 (April to December) turned into a profit of 84 million yen (compared to a loss of 137 million yen in the same period last year).

In addition, the full-year forecast for consolidated operating profit/loss has been revised upward from the previous range of loss of 300 million to loss of 600 million yen to a new range of loss of 100 million to profit of 100 million yen.

In the most recent three-month period, from October to December (3Q), the consolidated operating profit/loss turned to a loss of 131 million yen (compared to a profit of 125 million yen in the same period last year). The operating profit/loss margin drastically worsened from 9.7% in the same period last year to -7.5%.

Note: If the earnings forecast is disclosed as a range, the article is based on the midpoint of that range.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 1,566 -667 -712 -747 -21.8 ー Feb 7, 2024 J-GAAP
Apr - Dec, 2024 3,036 -137 -161 -187 -4.7 ー Feb 12, 2025 J-GAAP
Apr - Dec, 2025 5,018 84 -134 -142 -2.9 ー Feb 12, 2026 J-GAAP
YoY +65.3% － +16.8% +24.1% +37.3%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 2,474 -665 ー ー － 0 Nov 13, 2025 J-GAAP
Oct - Mar, 2025 New 2,974 -215 ー ー － 0 Feb 12, 2026 J-GAAP
Revision Rate +20.2% +67.7% － － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 5,750 -450 ー ー － 0 Nov 13, 2025 J-GAAP
Mar, 2026 New 6,250 0 ー ー － 0 Feb 12, 2026 J-GAAP
Revision Rate +8.7% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 3,333 289 272 220 5.5 0 May 13, 2025 J-GAAP
Oct - Mar, 2025 Guidance 2,974 -215 ー ー － 0 Feb 12, 2026 J-GAAP
YoY -10.8% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 5,082 27 5 -21 -0.5 0 May 13, 2025 J-GAAP
Mar, 2026 Guidance 6,250 0 ー ー － 0 Feb 12, 2026 J-GAAP
YoY +23.0% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 1,287 125 106 54 1.4 9.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 2,046 164 166 166 4.1 8.0 May 13, 2025 J-GAAP
Apr - Jun, 2025 1,720 184 175 157 3.3 10.7 Aug 13, 2025 J-GAAP
Jul - Sep, 2025 1,556 31 -99 -97 -2.0 2.0 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 1,742 -131 -210 -202 -4.2 -7.5 Feb 12, 2026 J-GAAP
YoY +35.4% － － － －

Related Articles